Go back

UK still ‘constrained’ in Covid vaccine manufacturing capacity


Royal Society scientists say extra capacity is needed in long-term at a reasonable price

The UK is “constrained” in its vaccine manufacturing capacity—meaning a potential vaccine against coronavirus will have to be prioritised for those most in need, Royal Society scientists have said.

While the UK has capacity to make influenza vaccines and some childhood vaccines, it is “limited in the availability of sites for further work within the UK”, according to a new report from the learned society’s Data Evaluation and Learning for Viral Epidemics group.

This article is only available to *Research Professional subscribers. If you are a subscriber you can read the article in full on researchprofessional.com